Market Cap 128.57B
Revenue (ttm) 33.54B
Net Income (ttm) 4.66B
EPS (ttm) N/A
PE Ratio 17.51
Forward PE 17.47
Profit Margin 13.90%
Debt to Equity Ratio 0.60
Volume 4,739,222
Avg Vol 7,258,144
Day's Range N/A - N/A
Shares Out 1.28B
Stochastic %K 88%
Beta 0.71
Analysts Sell
Price Target $110.71

Company Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic va...

Industry: Medical Devices
Sector: Healthcare
Phone: 353 1 438 1700
Address:
Building Two, Parkmore Business Park West, Galway, Ireland
QuantitativeTrading_
QuantitativeTrading_ Jan. 23 at 1:07 PM
$MDT Europe Green Light for Sphere-360 Medtronic just received CE Mark approval for its Sphere-360 pulsed field ablation catheter to treat paroxysmal AFib in Europe. At the same time, the company completed the first patient cases in its Horizon 360 IDE pivotal trial in the U.S., where the device remains investigational. This puts $MDT in a strong position internationally while progressing toward potential U.S. approval. Big step forward in the AFib treatment space If this helps, tap @QuantitativeTrading_ $NUAI
1 · Reply
Oruveek70
Oruveek70 Jan. 23 at 12:57 PM
$MDT potential here imo. https://www.stocktitan.net/news/MDT/affera-tm-momentum-continues-as-medtronic-announces-ce-mark-in-dwfpd7r63x35.html
0 · Reply
TheZaberWolf
TheZaberWolf Jan. 23 at 11:26 AM
0 · Reply
FlashRaiders
FlashRaiders Jan. 22 at 11:11 PM
0 · Reply
prismmarketview
prismmarketview Jan. 22 at 8:33 PM
$MDT Medtronic Invests $90M in Anteris Technologies for TAVR Development https://prismmarketview.com/medtronic-invests-90m-in-anteris-technologies-for-tavr-development/
1 · Reply
OptionSamurai
OptionSamurai Jan. 22 at 3:57 PM
$MDT appears in our scan that looks for calls that will explode if the stock goes to analyst target. ✔ Analysts rating is BUY ✔ The analyst target price is 9.9% away ✔ IV Percentile is 75.0% Call 105.0, 20-Mar-26 has: 💀 Max loss of 2.1% compared to holding shares ⚖ Breakeven is 5.5% away 📈 If the stock hits the target, the call will profit 211% 🔥 See more results & create your own scan here: https://bit.ly/3lR1xIP
0 · Reply
Arcides
Arcides Jan. 22 at 1:34 AM
$MDT pocket pivot in medtronic....
0 · Reply
LiquidThrone
LiquidThrone Jan. 21 at 7:24 PM
$MDT medtech defensive, slow accumulation, coil forming into healthcare flows
0 · Reply
junboi
junboi Jan. 21 at 3:50 PM
$MDT 🎯🤑 Back in this one yesterday. Building for ATH 2026 ✍️✍️
0 · Reply
Information_Master
Information_Master Jan. 21 at 1:53 PM
$AVR / $MDT just got a huge vote of confidence — the company is now valued at ~$450M. That’s massive, and it suggests the stock could run higher in the coming days. Many are stuck on the offering range and missing the bigger picture. This isn’t just paper talk — the underlying value shows real upside potential. Eyes on this one — smart money sees it differently than the crowd. Click to view @Information_Master for timely updates amid the volatility.
0 · Reply
Latest News on MDT
Medtronic: Don't Miss Out On This Dividend Aristocrat Now

Jan 21, 2026, 10:33 AM EST - 2 days ago

Medtronic: Don't Miss Out On This Dividend Aristocrat Now


Why Is Medtronic Stock Trading Higher After Analyst Upgrade

Jan 6, 2026, 2:38 PM EST - 17 days ago

Why Is Medtronic Stock Trading Higher After Analyst Upgrade


Best Dividend Aristocrats For January 2026

Dec 31, 2025, 8:47 AM EST - 23 days ago

Best Dividend Aristocrats For January 2026

ABBV ABT ADM ADP AFL ALB AMCR


MiniMed Group Files For IPO In Medtronic Carve-Out

Dec 22, 2025, 12:21 PM EST - 4 weeks ago

MiniMed Group Files For IPO In Medtronic Carve-Out

MMED


Medtronic: A Defensive Gem For Uncertain Times

Dec 20, 2025, 1:07 AM EST - 4 weeks ago

Medtronic: A Defensive Gem For Uncertain Times


Medtronic Spin-Off MiniMed Files for IPO

Dec 19, 2025, 4:53 PM EST - 4 weeks ago

Medtronic Spin-Off MiniMed Files for IPO

MMED


Medtronic's MiniMed files for US IPO

Dec 19, 2025, 4:16 PM EST - 4 weeks ago

Medtronic's MiniMed files for US IPO

MMED


Dividend Income: Lanny's October 2025 Summary

Dec 15, 2025, 3:29 AM EST - 5 weeks ago

Dividend Income: Lanny's October 2025 Summary

BNL BNS BRT CAH CM CSCO DEO


Medtronic: This Dividend Aristocrat Is Just Getting Started

Dec 9, 2025, 10:41 AM EST - 6 weeks ago

Medtronic: This Dividend Aristocrat Is Just Getting Started


Best Dividend Aristocrats For December 2025

Nov 29, 2025, 8:02 AM EST - 7 weeks ago

Best Dividend Aristocrats For December 2025

ABBV ABT ADM ADP AFL ALB AMCR


Medtronic plc (MDT) Q2 2026 Earnings Call Transcript

Nov 18, 2025, 12:08 PM EST - 2 months ago

Medtronic plc (MDT) Q2 2026 Earnings Call Transcript


Medtronic Lifts Outlook as Quarterly Profit, Sales Rise

Nov 18, 2025, 7:44 AM EST - 2 months ago

Medtronic Lifts Outlook as Quarterly Profit, Sales Rise


Medtronic: Possible Earnings Beat Incoming But Still Overvalued

Nov 11, 2025, 4:04 PM EST - 2 months ago

Medtronic: Possible Earnings Beat Incoming But Still Overvalued


Best Dividend Aristocrats For November 2025

Nov 1, 2025, 10:25 AM EDT - 2 months ago

Best Dividend Aristocrats For November 2025

ABBV ABT ADM ADP AMCR AOS ATO


Medtronic: A Revitalized Dividend Aristocrat To Buy Now

Oct 26, 2025, 12:12 PM EDT - 3 months ago

Medtronic: A Revitalized Dividend Aristocrat To Buy Now


Medtronic Stock's $50 Billion Gift To Investors

Oct 13, 2025, 6:45 AM EDT - 3 months ago

Medtronic Stock's $50 Billion Gift To Investors


Medtronic plc - Special Call

Oct 9, 2025, 2:56 PM EDT - 3 months ago

Medtronic plc - Special Call


Medtronic: FY26 Outlook Strengthened By New Product Launches

Sep 25, 2025, 8:13 AM EDT - 4 months ago

Medtronic: FY26 Outlook Strengthened By New Product Launches


Medtronic: Buy This Dividend Aristocrat While It's Good Value

Sep 17, 2025, 11:59 AM EDT - 4 months ago

Medtronic: Buy This Dividend Aristocrat While It's Good Value


QuantitativeTrading_
QuantitativeTrading_ Jan. 23 at 1:07 PM
$MDT Europe Green Light for Sphere-360 Medtronic just received CE Mark approval for its Sphere-360 pulsed field ablation catheter to treat paroxysmal AFib in Europe. At the same time, the company completed the first patient cases in its Horizon 360 IDE pivotal trial in the U.S., where the device remains investigational. This puts $MDT in a strong position internationally while progressing toward potential U.S. approval. Big step forward in the AFib treatment space If this helps, tap @QuantitativeTrading_ $NUAI
1 · Reply
Oruveek70
Oruveek70 Jan. 23 at 12:57 PM
$MDT potential here imo. https://www.stocktitan.net/news/MDT/affera-tm-momentum-continues-as-medtronic-announces-ce-mark-in-dwfpd7r63x35.html
0 · Reply
TheZaberWolf
TheZaberWolf Jan. 23 at 11:26 AM
0 · Reply
FlashRaiders
FlashRaiders Jan. 22 at 11:11 PM
0 · Reply
prismmarketview
prismmarketview Jan. 22 at 8:33 PM
$MDT Medtronic Invests $90M in Anteris Technologies for TAVR Development https://prismmarketview.com/medtronic-invests-90m-in-anteris-technologies-for-tavr-development/
1 · Reply
OptionSamurai
OptionSamurai Jan. 22 at 3:57 PM
$MDT appears in our scan that looks for calls that will explode if the stock goes to analyst target. ✔ Analysts rating is BUY ✔ The analyst target price is 9.9% away ✔ IV Percentile is 75.0% Call 105.0, 20-Mar-26 has: 💀 Max loss of 2.1% compared to holding shares ⚖ Breakeven is 5.5% away 📈 If the stock hits the target, the call will profit 211% 🔥 See more results & create your own scan here: https://bit.ly/3lR1xIP
0 · Reply
Arcides
Arcides Jan. 22 at 1:34 AM
$MDT pocket pivot in medtronic....
0 · Reply
LiquidThrone
LiquidThrone Jan. 21 at 7:24 PM
$MDT medtech defensive, slow accumulation, coil forming into healthcare flows
0 · Reply
junboi
junboi Jan. 21 at 3:50 PM
$MDT 🎯🤑 Back in this one yesterday. Building for ATH 2026 ✍️✍️
0 · Reply
Information_Master
Information_Master Jan. 21 at 1:53 PM
$AVR / $MDT just got a huge vote of confidence — the company is now valued at ~$450M. That’s massive, and it suggests the stock could run higher in the coming days. Many are stuck on the offering range and missing the bigger picture. This isn’t just paper talk — the underlying value shows real upside potential. Eyes on this one — smart money sees it differently than the crowd. Click to view @Information_Master for timely updates amid the volatility.
0 · Reply
OpenOutcrier
OpenOutcrier Jan. 21 at 1:50 PM
$AVR (+5.2% pre) $MDT Medtronic to Take Up to 19.99% Anteris Stake in $90M Deal https://ooc.bz/l/90199
0 · Reply
ZacksResearch
ZacksResearch Jan. 21 at 1:31 PM
$ISRG vs. $MDT: Which MedTech Giant Offers Better Returns? 🤔 Intuitive Surgical boasts a pure-play focus on robotic-assisted surgery, with 85% of revenues from recurring sources and a 39% operating margin, backed by strong cash flow and reinvestment capacity. Meanwhile, Medtronic faces tariff headwinds and uneven strategic momentum in robotics, impacting its segment recovery. Discover why Intuitive Surgical shines brighter in the long run 👉 https://www.zacks.com/stock/news/2820185/isrg-vs-mdt-which-medtech-stock-is-a-better-bet-now?cid=sm-stocktwits-2-2820185-body-29784&ADID=SYND_STOCKTWITS_TWEET_2_2820185_BODY_29784
0 · Reply
ZacksResearch
ZacksResearch Jan. 21 at 12:31 PM
$ISRG vs. $MDT — which MedTech stock actually has the edge right now? 🤖 Intuitive Surgical’s pure-play robotics focus, rising da Vinci 5 utilization, and 85% recurring revenues tilt the risk-reward compared with diversified Medtronic. Clear contrast in business models and visibility. See which setup looks more compelling here 👉 https://www.zacks.com/stock/news/2820185/isrg-vs-mdt-which-medtech-stock-is-a-better-bet-now?cid=sm-stocktwits-2-2820185-teaser-29782&ADID=SYND_STOCKTWITS_TWEET_2_2820185_TEASER_29782
0 · Reply
QuantitativeTrading_
QuantitativeTrading_ Jan. 21 at 12:00 PM
$AVR +13% premarket! Anteris Technologies spikes after announcing a $200M offering + strategic $90M investment from Medtronic $MDT (16–19.99% stake). Funds to fuel DurAVR transcatheter valve PARADIGM trial and expand manufacturing capacity — giving the company a stronger clinical runway. Big endorsement from Medtronic, and traders are taking notice! If this helps, tap @QuantitativeTrading_
0 · Reply
LilJimmy007
LilJimmy007 Jan. 21 at 11:35 AM
$AVR company needed that cash injection to fund paradigm trial through this year and scale manufacturing, necessary dilution that also comes with backing from $MDT, plenty of potential here for long term holders
0 · Reply
StocktwitsNews
StocktwitsNews Jan. 21 at 10:46 AM
Why Did AVR Stock Surge Pre-Market Today? $AVR $MDT $IWM $URTY https://stocktwits.com/news/equity/markets/why-did-avr-stock-surge-pre-market-today/cmUDFTBR4fG
0 · Reply
MoneyMakingCasino
MoneyMakingCasino Jan. 20 at 11:15 PM
$AVR next headline will be $MDT bought it for all cash deal
0 · Reply
GotCoins86
GotCoins86 Jan. 20 at 10:40 PM
$AVR $MDT wants 20% of AVR big news
0 · Reply
SelectiveTrader
SelectiveTrader Jan. 20 at 10:27 PM
$AVR some action after $MDT agreed to buy shares "$200 million of shares of its common stock through a proposed underwritten public offering (the “Offering”). In addition, the Company intends to grant the underwriters a 30-day option to purchase an additional $30 million...**Anteris has agreed to sell to Medtronic plc **(through a wholly owned subsidiary) in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), and at a price per share equal to the public offering price in the Offering, up to $90.0 million of shares of common stock, subject to a minimum purchase of 16.0% " https://finviz.com/news/281501/anteris-technologies-global-corp-announces-proposed-200-million-public-offering-of-common-stock-and-strategic-investment-from-medtronic
0 · Reply
prismmarketview
prismmarketview Jan. 16 at 6:37 PM
Medtronic $MDT Partners With Precision Neuroscience to Integrate Brain-Computer Interface Into Surgical Navigation Platform https://prismmarketview.com/medtronic-partners-with-precision-neuroscience-to-integrate-brain-computer-interface-into-surgical-navigation-platform/
0 · Reply
Lakeview22
Lakeview22 Jan. 15 at 7:04 PM
$MDT way undervalued. too good. IYKYK
0 · Reply
junboi
junboi Jan. 15 at 4:37 PM
$MDT 🤑🤑✍️ Waiting for re-entry dividend pays tomorrow 🤔
1 · Reply